Home › Funds › Lion Point Capital, LP › ARDX
Lion Point Capital, LP position in ARDX
ARDELYX INC · Health Care
Lion Point Capital, LP reported holding 128,650 shares of ARDX (ARDELYX INC) in its Q2 2026 13F filing — a position valued at US$656K, representing 3.14% of its reported portfolio and ranking #13 among its reported holdings. Lion Point Capital, LP has disclosed ARDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's ARDX position evolved
Lion Point Capital, LP first disclosed a stake in ARDX in Q3 2023 at 1,176,667 shares (US$4.8M). The position peaked in Q1 2024 at 1,046,667 shares, worth US$7.6M. Across 12 filings, Lion Point Capital, LP increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 128,650 shares valued at US$656K. Notable position changes include a 57% trim in Q3 2024 (shares fell 26% over the following quarter), a 51% trim in Q3 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.18M | $4.80M | New |
| Q4 2023 | 1.15M | $7.14M | Reduce |
| Q1 2024 | 1.05M | $7.64M | Reduce |
| Q2 2024 | 856.67K | $6.35M | Reduce |
| Q3 2024 | 370.00K | $2.55M | Reduce |
| Q4 2024 | 335.40K | $1.70M | Reduce |
| Q1 2025 | 335.40K | $1.65M | Hold |
| Q2 2025 | 335.40K | $1.31M | Hold |
| Q3 2025 | 162.75K | $896.75K | Reduce |
| Q4 2025 | 128.65K | $750.03K | Reduce |
| Q1 2026 | 128.65K | $770.61K | Hold |
| Q2 2026 | 128.65K | $656.12K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARDX and 13F data
ARDX (ARDELYX INC) is a Health Care company. 34 other funds we track also report a position in ARDX — the largest reported positions include Rubric Capital Management LP (US$82.6M), AIGH Capital Management LLC (US$16.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARDX
- Rubric Capital Management LP 16.20M sh · $82.63M · Q2 2026
- AIGH Capital Management LLC 3.20M sh · $16.32M · Q2 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held ARDX?
Lion Point Capital, LP has disclosed ARDX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Lion Point Capital, LP's current position in ARDX?
As of Q2 2026, Lion Point Capital, LP holds 128.65K shares of ARDX (ARDELYX INC), valued at $656.12K, representing 3.14% of its reported portfolio and ranking #13.
Has Lion Point Capital, LP been buying or selling ARDX?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in ARDX. The position peaked in Q1 2024 at 1.05M shares.
Which other funds hold ARDX?
Other major institutional holders of ARDX include Rubric Capital Management LP, AIGH Capital Management LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.